Previous close | 745.95 |
Open | 749.16 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1100 |
Day's range | 722.11 - 750.01 |
52-week range | 370.68 - 800.78 |
Volume | |
Avg. volume | 3,050,669 |
Market cap | 690.551B |
Beta (5Y monthly) | 0.37 |
PE ratio (TTM) | 124.80 |
EPS (TTM) | 5.82 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | 5.20 (0.70%) |
Ex-dividend date | 14 Feb 2024 |
1y target est | 826.94 |
Eli Lilly and Company (LLY) shares are up in 2024 to the tune of 28% so far. Looking under the surface, it’s clear to see why this biopharmaceuticals stock is so powerful.
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
In this article, we discuss the 13 best low volatility stocks to buy according to hedge funds. To skip the detailed analysis of the current market conditions, go directly to the 5 Best Low Volatility Stocks to Buy According to Hedge Funds. The S&P 500 had a remarkable year in 2023 and the first quarter […]